Hengrui (Group)

https://www.hengrui.com

Hengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialisation of high-quality medicines to address unmet clinical needs. With a global R&D team that includes 14 R&D centres and more than 5,500 professionals, Hengrui Pharma’s therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. To date, Hengrui has commercialised 23 new molecular entity drugs and 4 other innovative drugs in China. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology. *

	Start	2020-04-19 existent
	Industry	pharmaceutical

	City	n. a. Jiangsu province
		Address record changed: 2023-10-30

Basic data	Employees	n. a.

		* Document for »About Section«: GSK plc. (7/28/25). "Press Release: GSK and Hengrui Pharma Enter Agreements to Develop up to 12 Innovative Medicines across Respiratory, Immunology & Inflammation and Oncology". London.

		Record changed: 2026-05-02